Nature GeneticsCancer BiologyPeer-reviewed journal article
Cancer-independent, second somatic NF1 mutation of normal tissues in neurofibromatosis type 1
Thomas R. W. OliveriD, Andrew R. J. LawsoniD, Henry Lee-SixiD, Anna Tollit, Hyunchul JungiD, Yvette E. Hooks, Rashesh SanghviiD, Matthew D. YoungiD, Timothy M. ButleriD, Pantelis A. NicolaiD, Taryn D. TregeriD, Stefanie V. Lensing, G.A. Amos BurkeiD, Kristian AquilinaiD, Ulrike LöbeliD, Isidro Cortés‐CirianoiD, Darren R. HargraveiD, Mette JørgenseniD, Flora A. Jessop, Tim H. H. CoorensiD, Adrienne Margaret FlanaganiD, Kieren S. J. AllinsoniD, Iñigo MartincorenaiD, Thomas S. JacquesiD, Sam BehjatiiD
Abstract
INTRODUCTIONCancer predisposition syndromes mediated by recessive cancer genes generate tumours via somatic variants (second hits) in the unaffected allele. Second hits may or may not be sufficient for neoplastic transformation. Here, we performed whole genome and exome sequencing on 479 tissue biopsies from a child with neurofibromatosis type 1, a multi-system cancer-predisposing syndrome mediated by constitutive monoallelic NF1 inactivation. We identified multiple independent NF1 driver variants in histologically normal tissues, but not in 610 biopsies from two non-predisposed children. We corroborated this finding using targeted duplex sequencing, including a further nine adults with the same syndrome. Overall, truncating NF1 mutations were under positive selection in normal tissues from individuals with neurofibromatosis type 1. We demonstrate that normal tissues in neurofibromatosis type 1 commonly harbour second hits in NF1, the extent and pattern of which may underpin the syndromes cancer phenotype.
- organism: human
- assay: whole-exome sequencing
- assay: whole-genome sequencing
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: variant calling
- approach: experimental assay
- Citations
- 14
- FWCI
- 7.81
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pervasive Somatic Mutations in NF1 Drive Cell Type and Spatially Specific Clonal Selection in Neurofibromatosis
Daniel A. Snellings, Kow Essuman, … Christopher A. Walsh·bioRxiv·Sep 30, 2026
- A genotype-first approach identifies high incidence of NF1 pathogenic variants with distinct disease associations
Anton Mikhailovich Safonov, Tomoki T. Nomakuchi, … Theodore G. Drivas·Nature CommunicationsPeer-reviewed·Apr 1, 2025
- Integrative analysis identifies candidate tumor microenvironment and intracellular signaling pathways that define tumor heterogeneity in NF1
Jineta Banerjee, Robert J. Allaway, … Sara J.C. Gosline·GenesPeer-reviewed·Feb 21, 2020
- Specific HLA Class I and II alleles are associated with a higher risk for tumor formation in Neurofibromatosis type 1
Jonathan Sussman, Stephanie Nicole Brosius, … Thomas De Raedt·medRxiv·May 5, 2026
- Immortalization and Characterization of Schwann Cell Lines Derived from NF1 Associated Cutaneous Neurofibromas
Hua Li, Alexander Pemov, … Margaret R. Wallace·PLoS ONEPeer-reviewed·Jan 21, 2026
- Single-Cell Comparison of Schwann and Fibroblast Cells Reveals Distinct Transcriptional Programs in NF1-Associated Neurofibromas
Grace Swanson, Marcia Arenas‐Hernandez, Katherine Gurdziel·bioRxiv·Sep 26, 2025